HOME > Investors > Press Releases
2009-07-17
ViroMed Appoints Yongsoo Kim as Co-CEO
2009-06-01
ViroMed CEO to Present Results of VM202 Clinical Trials to ASGT
2009-05-07
ViroMed Records Surplus
2009-07-21
ViroMed Receives US FDA Approval of Phase II Trial for VM202 to Treat Peripheral Artery Disease
2009-06-09
Completion of Injections for China VM202 Phase I Trial
11 12 13 14 15 16 17 18 19